Time To Next Anti-Lymphoma Therapy (Ttnt) And Treatment-Free Interval (Tfi) With Bortezomib-Rituximab (Vcr) Vs Rituximab (R) In Patients (Pts) With Relapsed Follicular Lymphoma (Fl)
AuthID
P-002-R39
P-002-R39